SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Stahle M) "

Sökning: WFRF:(Stahle M)

Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Tsoi, Lam C, et al. (författare)
  • Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity
  • 2012
  • Ingår i: Nature genetics. - 1546-1718. ; 44:12, s. 1341-1348
  • Tidskriftsartikel (refereegranskat)abstract
    • To gain further insight into the genetic architecture of psoriasis, we conducted a meta-analysis of 3 genome-wide association studies (GWAS) and 2 independent data sets genotyped on the Immunochip, including 10,588 cases and 22,806 controls. We identified 15 new susceptibility loci, increasing to 36 the number associated with psoriasis in European individuals. We also identified, using conditional analyses, five independent signals within previously known loci. The newly identified loci shared with other autoimmune diseases include candidate genes with roles in regulating T-cell function (such as RUNX3, TAGAP and STAT3). Notably, they included candidate genes whose products are involved in innate host defense, including interferon-mediated antiviral responses (DDX58), macrophage activation (ZC3H12C) and nuclear factor (NF)-κB signaling (CARD14 and CARM1). These results portend a better understanding of shared and distinctive genetic determinants of immune-mediated inflammatory disorders and emphasize the importance of the skin in innate and acquired host defense.
  •  
2.
  •  
3.
  •  
4.
  •  
5.
  • Chaurasia, Chandra S., et al. (författare)
  • AAPS-FDA workshop white paper: Microdialysis principles, application and regulatory perspectives
  • 2007
  • Ingår i: Pharmaceutical Research. - Springer. - 1573-904X. ; 24:5, s. 1014-1025
  • Tidskriftsartikel (refereegranskat)abstract
    • Many decisions in drug development and medical practice are based on measuring blood concentrations of endogenous and exogenous molecules. Yet most biochemical and pharmacological events take place in the tissues. Also, most drugs with few notable exceptions exert their effects not within the bloodstream, but in defined target tissues into which drugs have to distribute from the central compartment. Assessing tissue drug chemistry has, thus, for long been viewed as a more rational way to provide clinically meaningful data rather than gaining information from blood samples. More specifically, it is often the extracellular (interstitial) tissue space that is most closely related to the site of action (biophase) of the drug. Currently microdialysis (mu D) is the only tool available that explicitly provides data on the extracellular space. Although mu D as a preclinical and clinical tool has been available for two decades, there is still uncertainty about the use of mu D in drug research and development, both from a methodological and a regulatory point of view. In an attempt to reduce this uncertainty and to provide an overview of the principles and applications of mu D in preclinical and clinical settings, an AAPS-FDA workshop took place in November 2005 in Nashville, TN, USA. Stakeholders from academia, industry and regulatory agencies presented their views on mu D as a tool in drug research and development.
  •  
6.
  •  
7.
  •  
8.
  • Djureinovic, Dijana, et al. (författare)
  • Profiling cancer testis antigens in non-small-cell lung cancer
  • 2016
  • Ingår i: JCI Insight. - The American Society for Clinical Investigation. - 2379-3708. ; 1:10
  • Tidskriftsartikel (refereegranskat)abstract
    • Cancer testis antigens (CTAs) are of clinical interest as biomarkers and present valuable targets for immunotherapy. To comprehensively characterize the CTA landscape of non-small-cell lung cancer (NSCLC), we compared RNAseq data from 199 NSCLC tissues to the normal transcriptome of 142 samples from 32 different normal organs. Of 232 CTAs currently annotated in the Caner Testis Database (CTdatabase), 96 were confirmed in NSCLC. To obtain an unbiased CTA profile of NSCLC, we applied stringent criteria on our RNAseq data set and defined 90 genes as CTAs, of which 55 genes were not annotated in the CTdatabase, thus representing potential new CTAs. Cluster analysis revealed that CTA expression is histology dependent and concurrent expression is common. IHC confirmed tissue-specific protein expression of selected new CTAs (TKTL1, TGIF2LX, VCX, and CXORF67). Furthermore, methylation was identified as a regulatory mechanism of CTA expression based on independent data from The Cancer Genome Atlas. The proposed prognostic impact of CTAs in lung cancer was not confirmed, neither in our RNAseq cohort nor in an independent meta-analysis of 1,117 NSCLC cases. In summary, we defined a set of 90 reliable CTAs, including information on protein expression, methylation, and survival association. The detailed RNAseq catalog can guide biomarker studies and efforts to identify targets for immunotherapeutic strategies.
9.
  •  
10.
  • KOCKUM, I, et al. (författare)
  • Population analysis of protection by HLA-DR and DQ genes from insulin-dependent diabetes mellitus in Swedish children with insulin-dependent diabetes and controls
  • 1995
  • Ingår i: European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics. - 0960-7420. ; 22:6, s. 443-465
  • Tidskriftsartikel (refereegranskat)abstract
    • A negative association between insulin‐dependent diabetes mellitus (IDDM) and HLA‐DR, DQA1 or DQB1 was found in a large population‐based investigation of childhood‐onset patients (more than 420 patients) and controls (more than 340 controls) from Sweden. The relative risk was decreased for several haplotypes that were negatively associated with IDDM: DR15‐DQA1*0102‐DQB1*0602, DR7‐DQA1*0201‐DQB1*0303, DR14‐DQA1*0101‐DQB1*0503, DRI1‐DQAI*0501‐DQB1*0301, DR13‐DQA1*0103‐DQB1*0603 and DR4‐DQA1*0301‐DQB1*0301. In a relative predispositional effect (RPE) analysis, however, only the DR15‐DQA1*0102‐DQB1*0602 haplotype was significantly decreased, which suggests that the major protective effect for IDDM is carried by this haplotype. This was supported by the observation that all genotypes which were negatively associated with IDDM, except DR7/13, included at least one allele from the DR15‐DQA1*0102‐DQB1*0602 haplotype. Relative predispositional effect (RPE) analysis of genotypes showed further that the DR15‐DQA1*0102‐DQB1*0602 haplotype was also negatively associated with IDDM when combined with any other haplotype, whether negatively or positively associated with IDDM. This supports previous suggestions that DR15‐DQA1*0102‐DQB1*0602 acts dominantly. However, both the stratification and the predispositional allele test failed to distinguish the negative association between IDDM and DR15 from that of DQBT0602. On the other hand, these tests indicated that DQA1*0102 was not likely to explain the negative association between IDDM and the DR15‐DQA1*0102‐DQB1*0602 haplotype. We conclude that the
  •  
Skapa referenser, mejla, bekava och länka
Åtkomst
fritt online (5)
Typ av publikation
tidskriftsartikel (199)
konferensbidrag (38)
rapport (1)
Typ av innehåll
refereegranskat (177)
övrigt vetenskapligt (61)
Författare/redaktör
Stahle, M, (140)
Pivarcsi, A, (42)
Stahle, L (29)
Mallbris, L, (28)
Stahle, E (16)
Xu, N, (16)
visa fler...
Stahle, A. (16)
Eidsmo, L, (13)
Nikamo, P, (12)
Sánchez, F. (11)
LAMBE, M, (11)
Li, DQ (11)
Granath, F, (10)
Li, X (10)
Hagstromer, M, (10)
Borregaard, N. (9)
Weber, G. (8)
Iversen, L (8)
Blomqvist, L, (7)
Franzen, E, (7)
Carlén, L, (7)
Stahle, Lars (7)
Kockum, I. (6)
Bradley, M (6)
Nordström, Carl-Henr ... (6)
Hammarlund-Udenaes, ... (6)
Rudling, M, (6)
Ungerstedt, Urban (6)
Bolinder, Jan, (6)
Sandstedt, B, (6)
Gudbjornsson, B (6)
Shah, Vinod P. (6)
Sakuraba, K (6)
Chaurasia, Chandra S ... (6)
Bashaw, Edward D. (6)
Benfeldt, Eva (6)
Bullock, Ross (6)
Bungay, Peter M. (6)
DeLange, Elizabeth C ... (6)
Derendorf, Hartmut (6)
Elmquist, William F. (6)
Joukhadar, Christian (6)
Lunte, Craig E. (6)
Rollema, Hans (6)
Sawchuk, Ronald J. (6)
Cheung, Belinda W. Y ... (6)
Welty, Devin F. (6)
Yeo, Helen (6)
Cheuk, S, (6)
Serezal, IG, (6)
visa färre...
Lärosäte
Karolinska Institutet (217)
Lunds universitet (20)
Uppsala universitet (14)
Göteborgs universitet (9)
Linköpings universitet (4)
Kungliga Tekniska Högskolan (1)
visa fler...
Chalmers tekniska högskola (1)
visa färre...
Språk
Engelska (237)
Svenska (1)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (39)
Teknik (3)

År

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy